C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2009
12/23/2009	CN101611007A Novel JNK inhibitors
12/23/2009	CN101606522A N-aroyl tetrahydropyrimidine insecticide and preparation method thereof
12/23/2009	CN100572379C Cgrp receptor antagonists
12/23/2009	CN100572360C Isoquinoline compound and its salt preparation method and application
12/23/2009	CA2728408A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
12/23/2009	CA2728376A1 6-1h-imidazo-quinazoline and quinolines derivatives/mao inhibitors for treating depression
12/23/2009	CA2728373A1 Aryl ketone as mri
12/23/2009	CA2728054A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	CA2727251A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009	CA2726703A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009	CA2726508A1 Pyridine compounds
12/22/2009	US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide
12/22/2009	US7635774 Benzimidazole derivatives
12/22/2009	US7635713 Preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, eclampsia, or eosinophil disorder; use in combination with a phosphodiesterase inhibitor; e.g. (5Z)-7-{1-[3-hydroxy-4-(3-methylphenyl)butyl]-3-oxopyrrolidin-2-yl}hept-5-enoic acid
12/22/2009	US7635706 5HT4-antagonistic 4-(aminomethyl)-piperidine benzamides
12/22/2009	US7635702 Imidazole compounds as transforming growth factor (TGF) inhibitors
12/22/2009	US7635701 Pyrimidine derivatives and their use as CB2 modulators
12/22/2009	US7635664 For controlling undesirable plants
12/22/2009	CA2529032C Processes for the preparation of 1-[2-benzimidazol-1-yl) quinolin-8-yl] piperidin-4-ylamine derivatives
12/22/2009	CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/22/2009	CA2487306C Novel piperidine compound
12/22/2009	CA2479674C New therapeutic use of 5-aminoimidazole-4-carboxamide riboside (acadesine)
12/22/2009	CA2450142C Direct binding assay for identifying inhibitors of hcv polymerase
12/22/2009	CA2434813C Imidazole derivatives
12/22/2009	CA2362381C Amide compounds and medicinal use thereof
12/22/2009	CA2346563C Novel 2-[3-phenyl-2-propenyl]-1,2,3,4-tetrahydroxyisoquinoline derivatives, preparation method and use as fungicides
12/22/2009	CA2305803C Crystalline antifungal polymorph
12/22/2009	CA2262435C Preparation of sterically hindered amine ethers
12/22/2009	CA2114221C 1, 3-oxathiolane nucleoside analogues
12/17/2009	WO2009151016A1 Method for producing 1-biphenylmethylimidazole compound
12/17/2009	WO2009150614A1 Tetrazole compounds as orexin receptor antagonists
12/17/2009	WO2009150230A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009	WO2009150144A1 New gpr119modulators
12/17/2009	WO2009150094A1 Novel herbicides
12/17/2009	WO2009150093A1 Novel herbicides
12/17/2009	WO2009092590A3 2 -cyano phenyl sulfonamide derivatives useful as pesticides
12/17/2009	US20090312555 Process and intermediate compounds useful in the preparation of statins
12/17/2009	US20090312546 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
12/17/2009	US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009	US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
12/17/2009	US20090312369 Renin Inhibitors
12/17/2009	US20090312352 Compositions and methods for treatment of disease caused by yersinia spp infection
12/17/2009	US20090312343 Quinazoline derivatives as tyrosine kinase inhibitors
12/17/2009	US20090312341 Cyclic amine bace-1 inhibitors having a heterocyclic substituent
12/17/2009	US20090312325 Quinoline Derivatives As Phosphodiesterase Inhibitors
12/17/2009	US20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3
12/17/2009	US20090312317 Coumarin compounds and their use for treating cancer
12/17/2009	US20090312316 Novel compounds
12/17/2009	US20090312307 Heterocyclo inhibitors of potassium channel function
12/17/2009	US20090312304 Organic compounds
12/17/2009	US20090311710 Mutagenesis methods using ribavirin and/or rna replicases
12/17/2009	US20090311403 Method of Using Organic Compounds
12/17/2009	US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
12/17/2009	US20090311217 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/17/2009	CA2727684A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h4 receptor
12/17/2009	CA2727680A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009	CA2727607A1 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
12/17/2009	CA2727245A1 Imidazole derivatives useful as inhibitors of faah
12/17/2009	CA2727220A1 Method for producing a 1-biphenylmethylimidazole compound
12/17/2009	CA2726102A1 Tetrazole compounds as orexin receptor antagonists
12/16/2009	EP2133348A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
12/16/2009	EP2133347A1 1-biarylazetidinone derivatives
12/16/2009	EP2133340A1 Novel benzazepine derivatives
12/16/2009	EP2133078A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
12/16/2009	EP2132197A2 Substituted pyrimidines as adenosine receptor antagonists
12/16/2009	EP2131656A2 Phthalazine derivatives
12/16/2009	EP2035414B1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
12/16/2009	EP1888567B1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
12/16/2009	EP1805165B1 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mglur3 receptor antagonists
12/16/2009	CN101605781A Aryl carboxylic acid cyclohexyl amide derivatives
12/16/2009	CN101605780A New 2, 4-dianilinopyrimidines, preparation thereof as drugs,pharmaceutical compositions and use thereof essentially as IKK inhibitors
12/16/2009	CN101605777A Imidazoles as aldosterone synthase inhibitors
12/16/2009	CN101602760A Method for preparing olmesartan medoxomil
12/16/2009	CN101602757A 4-substituent-2-amido pyrimidine compound and preparation method thereof
12/16/2009	CN101602732A Derivative of acyl thiourea pyridine, method for preparing same and application thereof
12/16/2009	CN101602731A Metalloproteinase inhibitors
12/16/2009	CN100569769C Compounds with antibacterial activity
12/16/2009	CN100569768C 1,4-pyran derivative and use thereof
12/15/2009	US7632955 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure
12/15/2009	US7632857 Histamine H3 receptor agents, preparation and therapeutic uses
12/15/2009	US7632829 Diazepan derivatives
12/15/2009	CA2529611C Pyrimidine derivatives for the treatment of abnormal cell growth
12/15/2009	CA2502264C N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/15/2009	CA2481078C Method and compositions for the synthesis of bch-189 and related compounds
12/15/2009	CA2450567C High molecular weight hydroxyphenylbenzotriazole uv-absorbers for thin film applications
12/15/2009	CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors
12/15/2009	CA2342217C Process for producing stereoselective nitro compounds
12/10/2009	WO2009148599A1 Pyrrole compunds that modulate hsp90 activity
12/10/2009	WO2009147843A1 Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
12/10/2009	WO2009147221A1 Small molecule leptin receptor modulators
12/10/2009	WO2009147216A1 New pyridine derivatives as leptin receptor modulator mimetics
12/10/2009	WO2009147167A1 Indane derivatives as ampa receptor modulators
12/10/2009	WO2009147121A1 Carboxyl substituted indoles for use as ppar alpha modulators
12/10/2009	WO2009147079A1 3,4-dihydropyrimidine trpa1 antagonists
12/10/2009	WO2009146910A1 4, 6-diphenylpyrid-2-0nes against cancer
12/10/2009	WO2009146555A1 Hiv integrase inhibitors from pyridoxine
12/10/2009	WO2009095163A3 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
12/10/2009	WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity
12/10/2009	WO2009010521A3 Nir-inert substrates comprising bis-oxodihydroindolylen-benzodifuranones
12/10/2009	US20090306406 Method for preparing 1,3-disubstituted pyrrolidine compounds

1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 694